Both in Biotechnology
Passage Bio vs aTyr Pharma
Over the past year PASG returned −54.1% and ATYR returned −87.3%; their daily moves had a correlation of -0.04.
PASG −54.1% ATYR −87.3%Growth of $1, one year, split-adjusted
| Metric | PASG | ATYR |
|---|---|---|
| Price | $3.31 | $0.1233 |
| Market cap | $10.6M | $302.4K |
| Today | −1.33% | −0.56% |
| 1 month | −28.6% | −59.9% |
| 6 months | −38.2% | −83.9% |
| Year to date | −72.0% | −84.3% |
| 1 year | −54.1% | −87.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 1.6× |
| Net cash | $24.2M | $56.9M |
| Dividend yield | — | — |
| Volatility (60d) | 76.5% | 80.0% |
| Short % of float | 2.4% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).